2m 2m 2m 2m 2m 2m 2m
Aclaris Therap (ACRS)
NASDAQ
$4.42+$0.27 (+6.51%)
Price as of Nov 11, 2026 7:35 PM EST- $658.2MMarket Cap
- 80.43%1-Year Change
- BiotechnologyIndustry
Aclaris Therap (ACRS)
$4.42+$0.27 (+6.51%)
ACRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.15 | ||
Change | -$0.09 (-2.12%) | ||
Open | $4.19 | ||
High | $4.29 | ||
Low | $4.07 | ||
Previous Close | $4.24 | ||
Volume | 1,397,433 | ||
30-Day Average Volume | 2,686,746 | ||
1-Week Change | 10.96% | ||
1-Month Change | 8.36% | ||
1-Year Change | 80.43% | ||
3-Year Change | -12.72% | ||
5-Year Change | -73.83% | ||
Fundamentals | |||
Shares Outstanding | 158.6M | ||
Total Assets | $216.2M | ||
Market Cap | $658.2M | ||
Enterprise Value | $637.8M | ||
Period: QTR TTM FY | |||
Revenue | $300,000.00 | ||
Net Income | -$18.5M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$18.5M | ||
EBITDA | -$18.4M | ||
Net Working Capital | $99.0M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | 2,126 | ||
P/B | 4 | ||
P/E | -35 | ||
PEG | -2 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue